NEXUS AG (NXU.DE) Stock Fundamental Analysis
Europe - FRA:NXU - DE0005220909 - Common Stock
70.9 EUR
+0.2 (+0.28%)
Overall NXU gets a fundamental rating of 6 out of 10. We evaluated NXU against 11 industry peers in the Health Care Technology industry. NXU has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. NXU is valued quite expensive, but it does show an excellent growth. These ratings would make NXU suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
NXU had positive earnings in the past year.
NXU had a positive operating cash flow in the past year.
NXU had positive earnings in each of the past 5 years.
Each year in the past 5 years NXU had a positive operating cash flow.
1.2 Ratios
NXU has a Return On Assets of 6.82%. This is comparable to the rest of the industry: NXU outperforms 54.55% of its industry peers.
NXU has a Return On Equity (11.31%) which is comparable to the rest of the industry.
NXU has a Return On Invested Capital of 8.78%. This is in the better half of the industry: NXU outperforms 63.64% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NXU is in line with the industry average of 9.32%.
The last Return On Invested Capital (8.78%) for NXU is above the 3 year average (7.85%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.82% | ||
| ROE | 11.31% | ||
| ROIC | 8.78% |
ROA(3y)6.17%
ROA(5y)6.42%
ROE(3y)9.56%
ROE(5y)10.69%
ROIC(3y)7.85%
ROIC(5y)8.2%
1.3 Margins
Looking at the Profit Margin, with a value of 12.10%, NXU is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
In the last couple of years the Profit Margin of NXU has grown nicely.
NXU's Operating Margin of 15.58% is amongst the best of the industry. NXU outperforms 81.82% of its industry peers.
In the last couple of years the Operating Margin of NXU has grown nicely.
With a decent Gross Margin value of 85.51%, NXU is doing good in the industry, outperforming 72.73% of the companies in the same industry.
In the last couple of years the Gross Margin of NXU has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.58% | ||
| PM (TTM) | 12.1% | ||
| GM | 85.51% |
OM growth 3Y4.31%
OM growth 5Y3.41%
PM growth 3Y8.94%
PM growth 5Y9.93%
GM growth 3Y0.31%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
NXU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
NXU has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, NXU has more shares outstanding
NXU has a better debt/assets ratio than last year.
2.2 Solvency
NXU has an Altman-Z score of 5.50. This indicates that NXU is financially healthy and has little risk of bankruptcy at the moment.
NXU's Altman-Z score of 5.50 is amongst the best of the industry. NXU outperforms 100.00% of its industry peers.
NXU has a debt to FCF ratio of 0.41. This is a very positive value and a sign of high solvency as it would only need 0.41 years to pay back of all of its debts.
NXU has a Debt to FCF ratio of 0.41. This is amongst the best in the industry. NXU outperforms 81.82% of its industry peers.
NXU has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.05, NXU belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.41 | ||
| Altman-Z | 5.5 |
ROIC/WACC1.22
WACC7.22%
2.3 Liquidity
NXU has a Current Ratio of 1.93. This is a normal value and indicates that NXU is financially healthy and should not expect problems in meeting its short term obligations.
NXU has a better Current ratio (1.93) than 72.73% of its industry peers.
NXU has a Quick Ratio of 1.89. This is a normal value and indicates that NXU is financially healthy and should not expect problems in meeting its short term obligations.
NXU has a better Quick ratio (1.89) than 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.89 |
3. Growth
3.1 Past
NXU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.35%, which is quite impressive.
Measured over the past years, NXU shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.97% on average per year.
The Revenue has been growing slightly by 7.65% in the past year.
The Revenue has been growing by 12.11% on average over the past years. This is quite good.
EPS 1Y (TTM)30.35%
EPS 3Y17.9%
EPS 5Y20.97%
EPS Q2Q%25.55%
Revenue 1Y (TTM)7.65%
Revenue growth 3Y11.59%
Revenue growth 5Y12.11%
Sales Q2Q%11.17%
3.2 Future
Based on estimates for the next years, NXU will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.50% on average per year.
The Revenue is expected to grow by 10.47% on average over the next years. This is quite good.
EPS Next Y14.6%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
EPS Next 5YN/A
Revenue Next Year9.04%
Revenue Next 2Y10.1%
Revenue Next 3Y10.39%
Revenue Next 5Y10.47%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 37.71 indicates a quite expensive valuation of NXU.
NXU's Price/Earnings is on the same level as the industry average.
NXU is valuated rather expensively when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
NXU is valuated quite expensively with a Price/Forward Earnings ratio of 32.10.
NXU's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.73. NXU is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.71 | ||
| Fwd PE | 32.1 |
4.2 Price Multiples
NXU's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NXU is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.58 | ||
| EV/EBITDA | 15.99 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NXU does not grow enough to justify the current Price/Earnings ratio.
NXU has a very decent profitability rating, which may justify a higher PE ratio.
NXU's earnings are expected to grow with 15.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.58
PEG (5Y)1.8
EPS Next 2Y14.95%
EPS Next 3Y15.5%
5. Dividend
5.1 Amount
With a yearly dividend of 0.32%, NXU is not a good candidate for dividend investing.
NXU's Dividend Yield is comparable with the industry average which is at 3.59.
With a Dividend Yield of 0.32, NXU pays less dividend than the S&P500 average, which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
5.2 History
The dividend of NXU has a limited annual growth rate of 2.17%.
Dividend Growth(5Y)2.17%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
NXU pays out 11.69% of its income as dividend. This is a sustainable payout ratio.
NXU's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP11.69%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
FRA:NXU (9/10/2025, 7:00:00 PM)
70.9
+0.2 (+0.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners55.8%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.22B
Analysts45.71
Price Target71.4 (0.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
Yearly Dividend0.22
Dividend Growth(5Y)2.17%
DP11.69%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.9%
PT rev (3m)0.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.71 | ||
| Fwd PE | 32.1 | ||
| P/S | 4.56 | ||
| P/FCF | 24.58 | ||
| P/OCF | 20.34 | ||
| P/B | 4.26 | ||
| P/tB | 15.35 | ||
| EV/EBITDA | 15.99 |
EPS(TTM)1.88
EY2.65%
EPS(NY)2.21
Fwd EY3.12%
FCF(TTM)2.88
FCFY4.07%
OCF(TTM)3.49
OCFY4.92%
SpS15.55
BVpS16.63
TBVpS4.62
PEG (NY)2.58
PEG (5Y)1.8
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.82% | ||
| ROE | 11.31% | ||
| ROCE | 11.71% | ||
| ROIC | 8.78% | ||
| ROICexc | 15.25% | ||
| ROICexgc | N/A | ||
| OM | 15.58% | ||
| PM (TTM) | 12.1% | ||
| GM | 85.51% | ||
| FCFM | 18.55% |
ROA(3y)6.17%
ROA(5y)6.42%
ROE(3y)9.56%
ROE(5y)10.69%
ROIC(3y)7.85%
ROIC(5y)8.2%
ROICexc(3y)12.19%
ROICexc(5y)11.45%
ROICexgc(3y)147.03%
ROICexgc(5y)150.84%
ROCE(3y)10.47%
ROCE(5y)10.94%
ROICexcg growth 3Y-0.23%
ROICexcg growth 5Y4.33%
ROICexc growth 3Y3.77%
ROICexc growth 5Y2.6%
OM growth 3Y4.31%
OM growth 5Y3.41%
PM growth 3Y8.94%
PM growth 5Y9.93%
GM growth 3Y0.31%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.41 | ||
| Debt/EBITDA | 0.25 | ||
| Cap/Depr | 54.49% | ||
| Cap/Sales | 3.87% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 98.85% | ||
| Profit Quality | 153.36% | ||
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.89 | ||
| Altman-Z | 5.5 |
F-Score8
WACC7.22%
ROIC/WACC1.22
Cap/Depr(3y)46.55%
Cap/Depr(5y)41.01%
Cap/Sales(3y)3.52%
Cap/Sales(5y)3.36%
Profit Quality(3y)122.34%
Profit Quality(5y)137.83%
High Growth Momentum
Growth
EPS 1Y (TTM)30.35%
EPS 3Y17.9%
EPS 5Y20.97%
EPS Q2Q%25.55%
EPS Next Y14.6%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
EPS Next 5YN/A
Revenue 1Y (TTM)7.65%
Revenue growth 3Y11.59%
Revenue growth 5Y12.11%
Sales Q2Q%11.17%
Revenue Next Year9.04%
Revenue Next 2Y10.1%
Revenue Next 3Y10.39%
Revenue Next 5Y10.47%
EBIT growth 1Y27.31%
EBIT growth 3Y16.4%
EBIT growth 5Y15.93%
EBIT Next Year66.24%
EBIT Next 3Y29.63%
EBIT Next 5YN/A
FCF growth 1Y122.1%
FCF growth 3Y16.82%
FCF growth 5Y17.03%
OCF growth 1Y112.34%
OCF growth 3Y17.98%
OCF growth 5Y15.93%